These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2497249)

  • 21. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy.
    Thompson CR; Hansen LM
    Fertil Steril; 1970 Dec; 21(12):844-53. PubMed ID: 5481991
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
    Traub AI; McFaul PB; Sheridan B; Leslie H
    Clin Reprod Fertil; 1987 Aug; 5(4):167-71. PubMed ID: 3130977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant gonadotropins.
    Lathi RB; Milki AA
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anovulatory sterility. Treatment with human menopausal gonadotropin and human chorionic gonadotropin].
    Espersen T; Møller J; Hansen KP
    Ugeskr Laeger; 1984 Feb; 146(9):640-3. PubMed ID: 6424295
    [No Abstract]   [Full Text] [Related]  

  • 29. Current experience with a standardized method of human menopausal gonadotropin/human chorionic gonadotropin administration.
    Radwanska E; Hammond J; Hammond M; Smith P
    Fertil Steril; 1980 May; 33(5):510-3. PubMed ID: 6768598
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of HMG-HCG administration on the vaginal epithelium, cervical mucus, endometrium and ovary.
    Silló-Seidl G
    Acta Eur Fertil; 1973 Sep; 4(3):109-12. PubMed ID: 4788936
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful pregnancy in a woman with Kallmann's syndrome using human menopausal gonadotropin followed by low-dose human chorionic gonadotropin in the mid-to-late follicular phase.
    Yu HT; Lee CL; Huang HY; Soong YK
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):300-2. PubMed ID: 22795116
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiology of the ovarian hyperstimulation syndrome.
    Haning RV; Strawn EY; Nolten WE
    Obstet Gynecol; 1985 Aug; 66(2):220-4. PubMed ID: 3927208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
    Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
    Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years of clinical experiences with human gonadotropins.
    Cittadini E; Quartararo P; Catalano G
    Acta Eur Fertil; 1974 Jun; 5(2):149-79. PubMed ID: 4411100
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Plasma oestradiol and progesterone estimations in the monitoring of the induction of ovulation by human menopausal gonadotrophin and human chorionic gonadotrophin.
    McGarrigle HH; Radwanska E; Little V; Swyer GI
    J Endocrinol; 1974 May; 61(2):LXXXI-LXXXII. PubMed ID: 4835931
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of gonadotropins and LH-releasing hormone in the clinical practice].
    Groot Wassink K
    Z Arztl Fortbild (Jena); 1975 Oct; 69(20):1067-9. PubMed ID: 1108466
    [No Abstract]   [Full Text] [Related]  

  • 38. Pregnancy after direct intraperitoneal insemination.
    Seracchioli R; Melega C; Maccolini A; Cattoli M; Bulletti C; Bovicelli L; Flamigni C
    Hum Reprod; 1991 Apr; 6(4):533-6. PubMed ID: 1918303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corpus luteum function in ovulation stimulation with Pergonal].
    Pakhomova IA; Fanchenko ND
    Akush Ginekol (Mosk); 1983 Nov; (11):33-6. PubMed ID: 6421191
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnancy following treatment with human gonadotropins in primary unexplained infertility.
    Wang CF; Gemzell C
    Acta Obstet Gynecol Scand; 1979; 58(2):141-6. PubMed ID: 582232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.